Toronto Dominion Bank increased its holdings in Monsanto (NYSE:MON) by 17.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,334,899 shares of the basic materials company’s stock after acquiring an additional 198,053 shares during the quarter. Toronto Dominion Bank owned approximately 0.30% of Monsanto worth $155,733,000 at the end of the most recent quarter.
Several other institutional investors have also made changes to their positions in MON. Gradient Investments LLC acquired a new position in shares of Monsanto in the 4th quarter valued at $108,000. Elkfork Partners LLC acquired a new position in shares of Monsanto in the 4th quarter valued at $162,000. Truewealth LLC acquired a new position in shares of Monsanto in the 4th quarter valued at $163,000. Guyasuta Investment Advisors Inc. acquired a new position in shares of Monsanto in the 1st quarter valued at $202,000. Finally, Flinton Capital Management LLC increased its holdings in shares of Monsanto by 90.9% in the 4th quarter. Flinton Capital Management LLC now owns 1,764 shares of the basic materials company’s stock valued at $206,000 after acquiring an additional 840 shares during the period. 74.85% of the stock is currently owned by institutional investors and hedge funds.
A number of brokerages have recently commented on MON. ValuEngine cut shares of Monsanto from a “buy” rating to a “hold” rating in a report on Wednesday, May 2nd. BMO Capital Markets cut shares of Monsanto from an “outperform” rating to a “market perform” rating in a research note on Tuesday, April 10th. Argus cut shares of Monsanto from a “buy” rating to a “sell” rating in a research note on Monday, April 16th. Zacks Investment Research cut shares of Monsanto from a “hold” rating to a “sell” rating in a research note on Monday, April 9th. Finally, Sanford C. Bernstein reissued a “neutral” rating and issued a $119.00 price objective on shares of Monsanto in a research note on Monday, April 9th. Two analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have issued a buy rating to the company. Monsanto currently has a consensus rating of “Hold” and a consensus price target of $126.61.
Shares of Monsanto opened at $125.84 on Wednesday, according to Marketbeat. The firm has a market capitalization of $55.50 billion, a price-to-earnings ratio of 22.88, a PEG ratio of 2.60 and a beta of 0.95. Monsanto has a 1 year low of $114.19 and a 1 year high of $126.80. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.85 and a current ratio of 1.41.
Monsanto (NYSE:MON) last issued its earnings results on Thursday, April 5th. The basic materials company reported $3.22 EPS for the quarter, missing the consensus estimate of $3.31 by ($0.09). The company had revenue of $5.02 billion for the quarter, compared to analysts’ expectations of $5.34 billion. Monsanto had a return on equity of 37.31% and a net margin of 17.07%. Monsanto’s revenue for the quarter was down 1.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $3.19 earnings per share. equities research analysts expect that Monsanto will post 5.7 EPS for the current year.
Monsanto Company Profile
Monsanto Company, together with its subsidiaries, provides agricultural products for farmers worldwide. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. The Seeds and Genomics segment produces row crop seeds, including corn, soybean, cotton, and canola seeds under the DEKALB, Asgrow, and Deltapine brands; and vegetable seeds, such as tomato, pepper, melon, cucumber, squash, beans, broccoli, onions, lettuce, and others under the Seminis and De Ruiter brands.
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.